Ferring announces new analysis of Rekovelle® data relating to personalised medicine in fertility patients
Ferring appoints Lars Peter Brunse to Executive Board
Ferring appoints Aaron Graff to Executive Board
Paul Navarre joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.
Ferring International Center S.A.Ch. de la Vergognausaz 50 1162 Saint-PrexSwitzerland
Tel: +41 58 301 00 00Fax: +41 58 301 00 10
This global corporate website provides general information about the global Ferring Group. For information about Ferring or its products in a specific country, please select your country in the Global Locator. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. save where indicated otherwise. ©2017 Ferring B.V.